Monday
12.09.2024
9:51 AM
Login form
Search
Calendar
Entries archive

My site

Main » 2022 » September » 03

HOUSTON - Friday, 02. September 2022

Gene Austin to resign as CEO and become Chairman of the Board

Paul Langenbahn, President of Quorum, to become CEO

Moves are designed to propel cloud-first, connected technology vision and catalyze next phase of growth

(BUSINESS WIRE) -- Quorum Software (Quorum), a global software leader dedicated to the energy industry, announced today that Chief Executive Officer Gene Austin will be stepping down from this position to become the company’s Chairman of the Board of Directors and President Paul Langenbahn will succeed Austin and serve as both President and CEO. This transition will be effective October 1.

“It has been an honor and a privilege to serve as Quorum’s CEO,” said Austin. “The tremendous growth over the past four years including six successful acquisitions and the merger with Aucerna, has positioned Quorum as a global market leader in energy software, exceeding company ... Read more »

Views: 52 | Added by: africa-live | Date: 09.03.2022 | Comments (0)

-Spesolimab is a monoclonal antibody that inhibits interleukin-36 (IL-36) signaling and is the first treatment specifically approved for the treatment of generalized pustular psoriasis flares
-After one week of treatment, more than half of patients treated with SPEVIGO® (spesolimab) intravenous injection showed no visible pustules in the EFFISAYIL® 1 trial
-The approval of SPEVIGO® in the U.S. reinforces the successful acceleration of our late-stage portfolio to bring innovative medicines to patients faster

(BUSINESS WIRE)--The U.S. Food and Drug Administration is the first regulatory authority to approve spesolimab as a treatment option for generalized pustular psoriasis (GPP) flares in adults, Boehringer Ingelheim announced today. Spesolimab, marketed in the U.S. as SPEVIGO®, is a novel, selective antibody that blocks the activation of the interleukin-36 receptor (IL-36R), a signaling pathway within the immune system shown to be involved in the ... Read more »

Views: 64 | Added by: africa-live | Date: 09.03.2022 | Comments (0)

(BUSINESS WIRE) -- Moove, the world’s first mobility fintech and Uber’s largest vehicle supply partner in EMEA, is announcing its launch in London as part of its global expansion.

Moove, an African-born startup with a growing global customer base of mobility entrepreneurs, has launched in Europe with a 100% EV rent-to-buy model that provides access to brand new, zero-emissions vehicles for a flat weekly fee. Moove aims to be the largest EV partner on Uber’s platform in London with plans to scale to up to 10,000 vehicles by the end of 2025, creating sustainable earnings opportunities and contributing to the city’s net zero carbon emissions goals.

London is the global leader for Uber’s electrification efforts with over 6,000 EVs on the platform – the most of any Uber city. Moove’s London launch will enable Uber to progress towards its goal of becoming an all-electric platform in the capital by 2025.

Transforming mobilit ... Read more »

Views: 62 | Added by: africa-live | Date: 09.03.2022 | Comments (0)